Renal Cancer Stem Cells: Characterization and Targeted Therapies

Overview

Journal Stem Cells Int

Publisher Wiley

Specialty Cell Biology

Date 2016 Jun 14

PMID 27293448

Citations 25

Authors

Anna Julie Peired

Alessandro Sisti

Paola Romagnani

Affiliations

Soon will be listed here.

Abstract

Renal cell carcinoma (RCC) is a major neoplasm with high incidence in western countries. Tumors are heterogeneous and are composed of differentiated cancer cells, stromal cells, and cancer stem cells (CSCs). CSCs possess two main properties: self-renewal and proliferation. Additionally, they can generate new tumors once transplanted into immunodeficient mice. Several approaches have been described to identify them, through the expression of cell markers, functional assays, or a combination of both. As CSCs are involved in the resistance mechanisms to radio- and chemotherapies, several new strategies have been proposed to directly target CSCs in RCC. One approach drives CSCs to differentiate into cancer cells sensitive to conventional treatments, while the other proposes to eradicate them selectively. A series of innovative therapies aiming at eliminating CSCs have been designed to treat other types of cancer and have not been experimented with on RCC yet, but they reveal themselves to be promising. In conclusion, CSCs are an important player in carcinogenesis and represent a valid target for therapy in RCC patients.

Citing Articles

Insights into Personalized Care Strategies for Wilms Tumor: A Narrative Literature Review.

Karam S, Gebreil A, Alksas A, Balaha H, Khalil A, Ghazal M Biomedicines. 2024; 12(7).

PMID: 39062028 PMC: 11274555. DOI: 10.3390/biomedicines12071455.

Lysine-specific methyltransferase Set7/9 in stemness, differentiation, and development.

Daks A, Parfenyev S, Shuvalov O, Fedorova O, Nazarov A, Melino G Biol Direct. 2024; 19(1):41.

PMID: 38812048 PMC: 11137904. DOI: 10.1186/s13062-024-00484-z.

Sirtuins Affect Cancer Stem Cells via Epigenetic Regulation of Autophagy.

Sipos F, Muzes G Biomedicines. 2024; 12(2).

PMID: 38397988 PMC: 10886574. DOI: 10.3390/biomedicines12020386.

Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.

Li Y, Fang Y, Lyu Z, Zhu Y, Yang L J Transl Med. 2023; 21(1):686.

PMID: 37784157 PMC: 10546755. DOI: 10.1186/s12967-023-04575-9.

Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers.

Lasorsa F, Rutigliano M, Milella M, Ferro M, Pandolfo S, Crocetto F Int J Mol Sci. 2023; 24(17).

PMID: 37685983 PMC: 10487877. DOI: 10.3390/ijms241713179.

References

Huang B, Huang Y, Yao Z, Chen X, Guo S, Mao X . Cancer stem cell-like side population cells in clear cell renal cell carcinoma cell line 769P. PLoS One. 2013; 8(7):e68293. PMC: 3708929. DOI: 10.1371/journal.pone.0068293. View

Axelson H, Johansson M . Renal stem cells and their implications for kidney cancer. Semin Cancer Biol. 2012; 23(1):56-61. DOI: 10.1016/j.semcancer.2012.06.005. View

Toole B . Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities. Clin Cancer Res. 2009; 15(24):7462-7468. PMC: 2796593. DOI: 10.1158/1078-0432.CCR-09-0479. View

Naujokat C, Steinhart R . Salinomycin as a drug for targeting human cancer stem cells. J Biomed Biotechnol. 2012; 2012:950658. PMC: 3516046. DOI: 10.1155/2012/950658. View

Nishizawa S, Hirohashi Y, Torigoe T, Takahashi A, Tamura Y, Mori T . HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells. Cancer Res. 2012; 72(11):2844-54. DOI: 10.1158/0008-5472.CAN-11-3062. View

Bruno S, Bussolati B, Grange C, Collino F, Graziano M, Ferrando U . CD133+ renal progenitor cells contribute to tumor angiogenesis. Am J Pathol. 2006; 169(6):2223-35. PMC: 1762463. DOI: 10.2353/ajpath.2006.060498. View

Lichner Z, Saleh C, Subramaniam V, Seivwright A, Prudhomme G, Yousef G . miR-17 inhibition enhances the formation of kidney cancer spheres with stem cell/ tumor initiating cell properties. Oncotarget. 2014; 6(8):5567-81. PMC: 4467387. DOI: 10.18632/oncotarget.1901. View

Dubinski W, Gabril M, Iakovlev V, Scorilas A, Youssef Y, Faragalla H . Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis. Hum Pathol. 2011; 43(7):1037-43. DOI: 10.1016/j.humpath.2011.08.012. View

Delahunt B, Srigley J . The evolving classification of renal cell neoplasia. Semin Diagn Pathol. 2015; 32(2):90-102. DOI: 10.1053/j.semdp.2015.02.002. View

10.

Gassenmaier M, Chen D, Buchner A, Henkel L, Schiemann M, Mack B . CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis. Stem Cells. 2013; 31(8):1467-76. DOI: 10.1002/stem.1407. View

11.

Williams S, Anderson W, Santaguida M, Dylla S . Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century. Lab Invest. 2013; 93(9):970-82. DOI: 10.1038/labinvest.2013.92. View

12.

Xia P, Xu X . PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application. Am J Cancer Res. 2015; 5(5):1602-9. PMC: 4497429. View

13.

Yamashita M, Hirohashi Y, Torigoe T, Kusumoto H, Murai A, Imagawa T . Dnajb8, a Member of the Heat Shock Protein 40 Family Has a Role in the Tumor Initiation and Resistance to Docetaxel but Is Dispensable for Stress Response. PLoS One. 2016; 11(1):e0146501. PMC: 4709114. DOI: 10.1371/journal.pone.0146501. View

14.

Yap N, Rajandram R, Ng K, Pailoor J, Fadzli A, Gobe G . Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms. Biomed Res Int. 2015; 2015:476508. PMC: 4584050. DOI: 10.1155/2015/476508. View

15.

Abourbih S, Sircar K, Tanguay S, Kassouf W, Aprikian A, Mansure J . Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study. World J Surg Oncol. 2013; 11:298. PMC: 3842840. DOI: 10.1186/1477-7819-11-298. View

16.

Salvadori M . Antineoplastic effects of mammalian target of rapamycine inhibitors. World J Transplant. 2013; 2(5):74-83. PMC: 3782237. DOI: 10.5500/wjt.v2.i5.74. View

17.

Yao H, Zhang Y, Sun L, Liu Y . The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells. Biomaterials. 2014; 35(33):9208-23. DOI: 10.1016/j.biomaterials.2014.07.033. View

18.

Hughes C, Liew M, Sachdeva A, Bassan P, Dumas P, Hart C . SR-FTIR spectroscopy of renal epithelial carcinoma side population cells displaying stem cell-like characteristics. Analyst. 2010; 135(12):3133-41. DOI: 10.1039/c0an00574f. View

19.

Dallas N, Samuel S, Xia L, Fan F, Gray M, Lim S . Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res. 2008; 14(7):1931-7. DOI: 10.1158/1078-0432.CCR-07-4478. View

20.

Kovacs G, Akhtar M, Beckwith B, Bugert P, Cooper C, Delahunt B . The Heidelberg classification of renal cell tumours. J Pathol. 1997; 183(2):131-3. DOI: 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G. View